Clot-Busting Drugs Reduce Deaths from Pulmonary Embolism by Nearly Half

A pulmonary embolism is a blockage of one or more arteries in the lungs, primarily because of blood clots that travel there from the legs. Bringing clarity to a decades-long debate, a national team of researchers has found that adding clot-busting medications known as thrombolytics to conventional approaches when treating sudden-onset pulmonary embolism patients is associated with 47 percent fewer deaths than using standard intravenous or under-the-skin anticoagulant ...

Read More